VCIM
Velan Capital Investment Management Portfolio holdings
AUM
$99.9M
This Quarter Return
+13.1%
1 Year Return
+37.46%
3 Year Return
+659.14%
5 Year Return
–
10 Year Return
–
AUM
$94.1M
AUM Growth
+$94.1M
(+10%)
Cap. Flow
-$14.6M
Cap. Flow
% of AUM
-15.47%
Top 10 Holdings %
Top 10 Hldgs %
78.6%
Holding
35
New
10
Increased
3
Reduced
5
Closed
6
Top Buys
| 1 |
Heron Therapeutics
HRTX
|
$6.25M |
| 2 |
PNT
POINT Biopharma Global Inc. Common Stock
PNT
|
$3.6M |
| 3 |
Inspire Medical Systems
INSP
|
$2.52M |
| 4 |
OPTN
OptiNose
OPTN
|
$2.44M |
| 5 |
Tenet Healthcare
THC
|
$2.44M |
Top Sells
| 1 |
CFMS
Conformis, Inc. Common Stock
CFMS
|
$16.4M |
| 2 |
Immunocore
IMCR
|
$4.99M |
| 3 |
ADMA Biologics
ADMA
|
$4.92M |
| 4 |
Healthcare Services Group
HCSG
|
$3.27M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
$2.84M |
Sector Composition
| 1 | Healthcare | 99.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
ADMA Biologics
ADMA
$4.12B
| $15.5M | 13.71% | 4,000,000 -1,269,155 | -24% | -$4.92M |
|
|
2
Immunocore
IMCR
$1.62B
| $11.8M | 10.38% | 205,974 -87,411 | -30% | -$4.99M |
|
3
TELA Bio
TELA
$70.5M
| $8.58M | 7.58% | 746,087 | – | – |
|
|
HZNP
4
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $7.83M | 6.92% | 68,829 | – | – |
|
5
Lantheus
LNTH
$3.73B
| $7.64M | 6.75% | 150,000 -50,000 | -25% | -$2.55M |
|
|
OPTN
6
DELISTED
OptiNose
OPTN
| $6.47M | 5.72% | 3,496,861 +1,320,289 | +61% | +$2.44M |
|
|
7
Heron Therapeutics
HRTX
$207M
| $6.25M | 5.52% | +2,500,000 | New | +$6.25M |
|
|
QIPT
8
Quipt Home Medical
QIPT
$114M
| $3.77M | 3.33% | 800,000 | – | – |
|
|
PNT
9
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $3.6M | 3.18% | +494,136 | New | +$3.6M |
|
|
10
Inspire Medical Systems
INSP
$2.77B
| $2.52M | 2.23% | +10,000 | New | +$2.52M |
|
|
11
Tenet Healthcare
THC
$16.3B
| $2.44M | 2.16% | +50,000 | New | +$2.44M |
|
|
CTLT
12
DELISTED
CATALENT, INC.
CTLT
| $2.25M | 1.99% | +50,000 | New | +$2.25M |
|
13
Immatics
IMTX
$619M
| $2.18M | 1.92% | +250,000 | New | +$2.18M |
|
14
Edesa Biotech
EDSA
$16.3M
| $1.92M | 1.7% | +888,888 | New | +$1.92M |
|
|
15
Healthcare Services Group
HCSG
$1.13B
| $1.53M | 1.35% | 127,252 -272,748 | -68% | -$3.27M |
|
16
Jasper Therapeutics
JSPR
$45.5M
| $1.37M | 1.21% | 3,219,036 | – | – |
|
|
SGEN
17
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.29M | 1.14% | +10,000 | New | +$1.29M |
|
18
Sonida Senior Living
SNDA
$488M
| $1.04M | 0.91% | 82,832 | – | – |
|
19
Collegium Pharmaceutical
COLL
$1.22B
| $1.03M | 0.91% | 44,448 +4,491 | +11% | +$104K |
|
20
Rezolute
RZLT
$619M
| $828K | 0.73% | 400,000 | – | – |
|
|
BLU
21
DELISTED
BELLUS Health Inc.
BLU
| $822K | 0.73% | 100,000 | – | – |
|
22
Xenon Pharmaceuticals
XENE
$2.98B
| $789K | 0.7% | 20,000 | – | – |
|
|
ALIM
23
DELISTED
Alimera Sciences, Inc.
ALIM
| $699K | 0.62% | 257,753 +30,151 | +13% | +$81.7K |
|
|
CFMS
24
DELISTED
Conformis, Inc. Common Stock
CFMS
| $685K | 0.6% | 206,256 -4,950,150 | -96% | -$16.4M |
|
25
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $654K | 0.58% | +82,605 | New | +$654K |
|